The National Institutes of Health (NIH) has awarded a $1.7 million grant to Genomenon to accelerate development of the Mastermind Genomic Search Engine, the company’s AI-driven variant interpretation engine.
The grant was awarded through NIH’s Small Business Innovation Research (SBIR) program.
“Having already curated more than 250 genes for rare diseases and cancer, this NIH funding allows us to accelerate the pace of genetic interpretation for our AI-driven curation engine, which is a crucial first step in a process that enables targeted and efficient use of expert human curators,” said Mike Klein, CEO of Genomenon.
Used by more than 1,000 diagnostic labs and integrated into 18 clinical-grade decision support platforms and reference databases across the globe, Mastermind connects patient genetic data with critical evidence from scientific literature needed to diagnose rare genetic diseases and cancer.
